N. Virkajarvi et al., ASSOCIATION BETWEEN P53 OVEREXPRESSION, CELL-PROLIFERATION, TUMOR NECROSIS AND EXTENT OF APOPTOSIS IN OPERATED PANCREATIC ADENOCARCINOMA, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 105(10), 1997, pp. 765-772
In this study we investigated the immunohistochemical expression of th
e p53 protein in 44 ductal pancreatic adenocarcinomas and its relation
to cell proliferation, apoptosis and necrosis, three factors affectin
g tumor growth. The results were evaluated against survival and other
clinical parameters of the patients. p53-positivity was found in 18/44
(41%) of the tumors. A positive p53 status was significantly associat
ed with a high extent of necrosis (greater than or equal to 10% of tum
or tissue) (p=0.04, Fisher's exact test), with a high immunohistochemi
cal expression of PCNA (p=0.04, Fisher's exact test) and with a high m
itotic count (p=0.05, two-tailed t test). No statistically significant
association was found between p53-positivity and high or low extent o
f apoptosis as evaluated by in situ labeling of the 3'-ends of the DNA
fragments (p=0.34, Fisher's exact test). Patient survival was not ass
ociated with the p53 expression of the tumors or separately with tumor
cell proliferation, apoptosis or necrosis. The results suggest that a
n altered p53 function, as reflected by p53 overexpression, affects tu
mor growth by promoting cell proliferation and necrosis, but does not
show a significant association with the extent of apoptosis in operate
d pancreatic adenocarcinoma.